[Federal Register Volume 64, Number 62 (Thursday, April 1, 1999)]
[Notices]
[Page 15803]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-7936]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 1, 1998, and published in the Federal 
Register on October 9, 1998 (63 FR 54490), Ansys Diagnostics, Inc., 
25200 Commercentre Drive, Lake Forest, California 92630, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phencyclidine (7471).......................  II
1-Piperidinocyclohexanecarbonitrile (PCC)    II
 (8603)
Benzoylecgonine (9180).....................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
produce standards and controls for in-vitro diagnostic drug testing 
systems.
    DEA has considered the factors in Title 21, United States Code, 
section 823(a) and determined that the registration of Ansys 
Diagnostics, Inc. to manufacture the listed controlled substances is 
consistent with the public interest at this time. DEA has investigated 
Ansys Diagnostics, Inc. on a regular basis to ensure that the company's 
continued registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basis classes of controlled substances listed above 
is granted.

    Dated: March 17, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-7936 Filed 3-31-99; 8:45 am]
BILLING CODE 4410-09-M